danil21: ***Curaizon***

Curaizon

Solve the problem of drug abuse by spreading our technology through national health services.

" CURAIZON " improves health, reduces cost and excellent life, revolutionizes health and increases drug adherence through large-scale data analyzes delivered through a block-chain.

We solve the problems in the real world by helping patients to take their medicines properly

Every day millions of people fail to take their medication as definitely and the personal and financial costs that are generated are shocking. Worldwide, the mismatch generates $ 700 billion of medical expenses that can be avoided.

The data we are doing is unique and has tremendous value for pharmaceutical companies, researchers and the government.

Every time a patient uses our CuraServe technology, our data grows in value and value.

Curaizon ™ solves the problem of drug abuse by spreading our technology through national health services. As part of our decision, we collect complete anonymous data on how and when patients use drugs.

CuraTokens ™ is the only way to access our data. Points can be exchanged for access to data, which will improve medical research, reduce health care costs, and save lives.

CuraToken ™ values are based on real solutions to real issues.

What does the company do?

Our goal is to improve drug adherence and bring benefits that transform games for patients and healthcare providers by becoming a major provider of data compliance and solutions around the world.

What's unique about the company?

Our solutions work with patients, their families and healthcare providers to ensure that patients take their medicine as defined by a series of support tools backed by predictive modeling and behavioral analysis tools to improve adherence to medicines.

What problems does the company solve?

Our CuraServe technology helps ensure that patients take the medicine as determined by their physician. In this way, we help patients to live longer and healthier. We also reduce the cost of health care that occurs when patients fail to take their medication properly.

How do you create value to maintain CuraTokens?

CuraServe ™ technology we produce large amounts of unique and real-time data that shows how people use their most valuable drugs for different groups including pharmaceutical companies, medical researchers and bioteknologi.CuraTokens ™ companies allow the token owner to access data for create a request. When we started the decision of more patients in more countries. The more data we produce, the more valuable that CuraTokens ™ is.

Who is your target customer?

Curaizon ™ sells its compliance solutions (CuraServe ™) to national health services globally. Our end users are healthcare patients who take any form of medicine. We also work with industrial, pharmaceutical and biotech universities and other data users through our CuraData ™ solution.

What is your geographic target on the market?

Curaizon is targeting countries with national health services. At present, it covers 1.4 billion people and this number continues to grow.

What is the market potential?

Global cost of non-compliance amounts to more than € 600 billion each year and generates prematurely hundreds of thousands of lives. Compliance with chronic and long-term illness is less than 50%.

Curaizon ™ ecosystem

CuraToken ™ Utility Tokens (CTKN) allows symbol holders to access our exclusive and anonymous medical data in a block-chain.

CuraTokens ™ is the only way to access Curaizon ™ technology.

CuraToken ™ owners have access to data that uses strong analytics, predictions, AIs, and large data in the fight against drug misconduct.

CuraTokens ™ provides real-time analysis of patient behavior and compliance.

CuraTokens ™ allows the use of block authentication, privacy and reporting technology, allowing individuals to control their data, provide protection, security, and compliance with all necessary provisions, including GDPR.

CuraTokens ™ facilitates partnerships with medical and pharmaceutical organizations through the symbolic reward system.

CuraToken ™ owners know that they are saving lives around the world by helping to solve the problem of drug misconduct.

January 2016

Development of CuraServe ™ launch

June 2017

Perform a CuraServe ™ test

Феврари 2018 г.

Full release of Alpha CuraData ™

June 1, 2018

Run the current skip

June 8, 2018

Public sale of tokens

November 2018

Bura CuraData ™ complete

March 2019

CuraServe ™ Public Release

July 2019

Growth of the CuraData ™ platform

2020

Release Curadata ™ 2.0

Our team combines passion, innovation and experience with experience in healthcare, finance, operations, marketing and technology

LEADERS

BUSINESS DEVELOPS

TECHNOLOGY

IcoBox

Partner of the ICO campaign

ICOBox is the first and largest new generation of Blokchain Builders and Business Facilitators for companies that want to sell their products through crowds from ICO.

Technolabs portal

Software development

Global Information Technologies, Solutions and Engineering Companies with a team of intelligent and dedicated professionals who serve our customers in 30 countries across 5 continents.

Innohead

Big Data and Forecast Analysis

Companies with large data and predictive analytics focus on data mining and customer analysis.

Timengo

IoT, Cloud, and security experts

Timengo is an IoT, Cloud and Security expert with extensive experience and knowledge in the healthcare sector. They encourage our internal and external technology applications and help us provide a secure API infrastructure with an external database.

CLX

Provider of CPaaS Tier-1

CLX is the only CPaaS provider at Level 1 who trusts more than 25 billion transactions a year and is our Notification Partner.

CONSULTATIVE